Home » Pediatrics: Dermatologic Disease: Whats New? (Audio-Digest Foundation Pediatrics Continuing Medical Education (CME). Book 56) by Audio Digest
Pediatrics: Dermatologic Disease: Whats New? (Audio-Digest Foundation Pediatrics Continuing Medical Education (CME). Book 56) Audio Digest

Pediatrics: Dermatologic Disease: Whats New? (Audio-Digest Foundation Pediatrics Continuing Medical Education (CME). Book 56)

Audio Digest

Published
ISBN :
Kindle Edition
16 pages
Enter the sum

 About the Book 

Purpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide contentMorePurpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide content to help to solve those problems, and increase their application of knowledge to practice.Audio-Digest Pediatrics is specifically designed to provide the participant with state-of-the-art information, including, but not limited to, the diagnosis and management of:Allergy & seasonal concernsCardiopulmonary diseaseDermatologic problemsCancer in children and adolescentsFeverGastrointestinal problemsGenetic concernsHearing impairmentInfectious diseaseNeurologic problemsNewborn screeningNutritional concernsPsychosocial issuesRespiratory diseaseSports injuriesUrologic diseaseVisual impairmentThe goal of this program is to improve the management of pediatric dermatologic diseases. After hearing and assimilating this program, the clinician will be better able to:1: Prescribe treatment for neonatal and juvenile acne.2: Apply new developments in the treatment of atopic dermatitis.3: Identify causative microbes of common skin infections.4: Consider novel strategies for removal of warts in children.5: Weigh the advantages and disadvantages of standard and novel treatments of pediatric hemangiomas and pyogenic granulomas.